Alpha 2.0
Login Register
» Authors » Fabienne Pessione

Fabienne Pessione

Explore the profile of Fabienne Pessione including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 576
Followers 0
Related Specialties
General Surgery
General Medicine
Gastroenterology
Top 10 Co-Authors
Patricia Fauque
Philippe Jonveaux
Jacques de Mouzon
Sylvie Epelboin
Rachel Levy
Marie-Jose Gervoise-Boyer
Aviva Devaux
Marianne Bergere
Geraldine Viot
Julie Labrosse
Published In
Transplantation
Reprod Biomed Online
Presse Med
Liver Int
Chest
Affiliations
Soon will be listed here.
Recent Articles
1.
Higher risk of pre-eclampsia and other vascular disorders with artificial cycle for frozen-thawed embryo transfer compared to ovulatory cycle or to fresh embryo transfer following fertilization
Epelboin S, Labrosse J, de Mouzon J, Devaux A, Gervoise-Boyer M, Hesters L, et al.
Front Endocrinol (Lausanne) . 2023 Jun; 14:1182148. PMID: 37284215
Background: Risks of maternal morbidity are known to be reduced in pregnancies resulting from frozen embryo transfer (FET) compared to fresh-embryo transfer (-ET), except for the risk of pre-eclampsia, reported...
2.
Fetal growth disorders following medically assisted reproduction: due to maternal context or techniques? A national French cohort study
Sermondade N, Hesters L, de Mouzon J, Devaux A, Epelboin S, Fauque P, et al.
Reprod Biomed Online . 2023 Mar; 46(4):739-749. PMID: 36906455
Research Question: What part do maternal context and medically assisted reproduction (MAR) techniques play in the risk of fetal growth disorders? Design: This retrospective nationwide cohort study uses data available...
3.
Risk factors associated with preterm birth in singletons born after IVF: a national cohort study
Gervoise-Boyer M, Fauque P, de Mouzon J, Devaux A, Epelboin S, Levy R, et al.
Reprod Biomed Online . 2023 Mar; 46(4):750-759. PMID: 36868885
Research Question: What are the risk factors for prematurity other than intrauterine growth restriction in singletons after IVF? Design: Data were collected from a national registry, based on an observational...
4.
Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study
Epelboin S, Labrosse J, de Mouzon J, Fauque P, Gervoise-Boyer M, Levy R, et al.
PLoS Med . 2021 Nov; 18(11):e1003857. PMID: 34847147
Background: To the best of our knowledge, no study has exhaustively evaluated the association between maternal morbidities and Coronavirus Disease 2019 (COVID-19) during the first wave of the pandemic in...
5.
Endometriosis and assisted reproductive techniques independently related to mother-child morbidities: a French longitudinal national study
Epelboin S, Labrosse J, Fauque P, Levy R, Gervoise-Boyer M, Devaux A, et al.
Reprod Biomed Online . 2021 Jan; 42(3):627-633. PMID: 33388264
Research Question: Does endometriosis increase obstetric and neonatal complications, and does assisted reproductive technology (ART) cause additional risk of maternal or fetal morbidity? Design: A nationwide cohort study (2013-2018) comparing...
6.
Do in vitro fertilization, intrauterine insemination or female infertility impact the risk of congenital anomalies in singletons? A longitudinal national French study
Fauque P, de Mouzon J, Devaux A, Epelboin S, Gervoise-Boyer M, Levy R, et al.
Hum Reprod . 2020 Dec; 36(3):808-816. PMID: 33378527
Study Question: Do IVF, IUI or female infertility (i.e. endometriosis, polycystic ovary syndrome [PCOS] and primary ovarian insufficiency [POI]) lead to an increased risk of congenital anomalies in singletons? Summary...
7.
Reproductive technologies, female infertility, and the risk of imprinting-related disorders
Fauque P, de Mouzon J, Devaux A, Epelboin S, Gervoise-Boyer M, Levy R, et al.
Clin Epigenetics . 2020 Dec; 12(1):191. PMID: 33308308
Background: Epidemiological studies suggest that singletons born from assisted reproductive technologies (ART) have a high risk of adverse perinatal outcomes, specifically for imprinting disorders. Because ART processes take place at...
8.
Continuous Monitoring of Transplant Center Performance: Different Options for Different Goals
Alexandrine B, Savoye E, Pessione F, Cantrelle C, Jasseron C, Santin G, et al.
Transplantation . 2019 Feb; 103(9):1935-1944. PMID: 30720680
Background: In France, the need for continuous monitoring of transplant center performance has recently become apparent. Cumulative sum (CUSUM) monitoring of transplantation is already been used to monitor transplant outcomes...
9.
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria
Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, et al.
Gastroenterology . 2012 Jul; 143(4):986-94.e3. PMID: 22750200
Background & Aims: The aim of this study was to generate an improved prognostic model for predicting recurrence in liver transplant candidates with hepatocellular carcinoma (HCC). Methods: Predictors of recurrence...
10.
[Evaluation of liver transplant quality in France]
Loty B, Pessione F, Cantrelle C, Savoye E, Aubin F
Bull Acad Natl Med . 2008 Aug; 191(8):1617-26. PMID: 18666461
The French Biomedecine Agency evaluated the outcomes of liver transplantation in France. The one-year graft failure rate in each transplant center was compared with the national rate, after adjusting for...